Jusline 30/70 Sterile Suspension For Injection ( Sc ) Philippines - English - FDA (Food And Drug Administration)

jusline 30/70 sterile suspension for injection ( sc )

team excel distribution inc.; distributor: team excel distribution inc. - neutral insulin human , isophane insulin human, recombinant dna - sterile suspension for injection ( sc ) - 100 units/ml ( 30% as neutral insulin human/ 70% as isophane insulin human )

Humulin 30/70 New Zealand - English - Medsafe (Medicines Safety Authority)

humulin 30/70

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Mixtard 50/50 (Human) New Zealand - English - Medsafe (Medicines Safety Authority)

mixtard 50/50 (human)

novo nordisk pharmaceuticals ltd - insulin, human, recombinant dna origin 50 iu/ml; isophane insulin, human 50 iu/ml - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 50 iu/ml isophane insulin, human 50 iu/ml

Insulin Human Winthrop European Union - English - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

Humulin NPH New Zealand - English - Medsafe (Medicines Safety Authority)

humulin nph

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Humulin R New Zealand - English - Medsafe (Medicines Safety Authority)

humulin r

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: glycerol hydrochloric acid as 10% solution for ph adjustment metacresol sodium hydroxide as 10% solution for ph adjustment water for injection - humulin is indicated for the treatment of insulin-requiring diabetes mellitus.

Wosulin-30/70 100IU/mL Philippines - English - FDA (Food And Drug Administration)

wosulin-30/70 100iu/ml

ambica international corp.; distributor: gx laboratories, inc. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100iu/ml

Glysolin 30/70 100IU/mL Philippines - English - FDA (Food And Drug Administration)

glysolin 30/70 100iu/ml

ambica international corp.; distributor: the cathay yss distributors co., ltd. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100iu/ml

Unbranded 100 IU/mL Philippines - English - FDA (Food And Drug Administration)

unbranded 100 iu/ml

ambica international corporation; distributor: ambicare pharmaceuticals inc. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100 iu/ml

Actraphane HM New Zealand - English - Medsafe (Medicines Safety Authority)

actraphane hm

novo nordisk pharmaceuticals ltd - insulin, human, recombinant dna origin 70 iu/ml; isophane insulin, human 30 iu/ml - solution for injection - active: insulin, human, recombinant dna origin 70 iu/ml isophane insulin, human 30 iu/ml